EBITDA Margin: Earnings before interest, taxes, depreciation and amortization as a portion of total revenue. Calculated as: EBITDA / Total Revenues
Genmab A/S (GNMSF) had EBITDA Margin of 30.54% for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$3.72B |
|
$963.00M |
|
$238.00M |
|
$3.48B |
|
$2.65B |
|
$1.06B |
|
$139.00M |
|
$1.20B |
|
$1.20B |
|
$963.00M |
|
$963.00M |
|
$963.00M |
|
$963.00M |
|
$1.06B |
|
$1.14B |
|
62.15M |
|
62.69M |
|
$15.50 |
|
$15.37 |
|
| Balance Sheet Financials | |
$2.88B |
|
$153.00M |
|
$9.99B |
|
$12.87B |
|
$1.43B |
|
$5.00B |
|
$5.60B |
|
$7.03B |
|
$5.85B |
|
$-3.63B |
|
$5.85B |
|
64.24M |
|
| Cash Flow Statement Financials | |
$1.19B |
|
$-5.64B |
|
$4.79B |
|
$1.38B |
|
$1.72B |
|
$335.00M |
|
$128.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.02 |
|
-- |
|
-- |
|
0.46 |
|
0.90 |
|
93.60% |
|
28.63% |
|
28.63% |
|
|
EBITDA Margin |
30.54% |
32.37% |
|
25.89% |
|
$-6.07B |
|
-- |
|
-- |
|
-- |
|
0.29 |
|
13.22 |
|
3.23 |
|
113.03 |
|
16.47% |
|
-26.52% |
|
7.48% |
|
8.88% |
|
$91.02 |
|
$-96.76 |
|
$18.92 |
|